Review



leupeptin  (Santa Cruz Biotechnology)


Bioz Verified Symbol Santa Cruz Biotechnology is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 92

    Structured Review

    Santa Cruz Biotechnology leupeptin
    Leupeptin, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 10 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/leupeptin/pm41888978-96-88-89?v=Santa+Cruz+Biotechnology
    Average 92 stars, based on 10 article reviews
    leupeptin - by Bioz Stars, 2026-07
    92/100 stars

    Images



    Similar Products

    93
    Gold Biotechnology Inc leupeptin hemisulfate
    Leupeptin Hemisulfate, supplied by Gold Biotechnology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/leupeptin/custom%40l-010%4042398503?v=Gold+Biotechnology+Inc
    Average 93 stars, based on 1 article reviews
    leupeptin hemisulfate - by Bioz Stars, 2026-07
    93/100 stars
      Buy from Supplier

    95
    MedChemExpress hy 18234a aprotinin mce
    Hy 18234a Aprotinin Mce, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/leupeptin/10__1016_slash_j__cub__2026__02__055-159-107-109?v=MedChemExpress
    Average 95 stars, based on 1 article reviews
    hy 18234a aprotinin mce - by Bioz Stars, 2026-07
    95/100 stars
      Buy from Supplier

    94
    Thermo Fisher leupeptin hemisulfate
    Study the impact of TLR7 on the autophagy level in lung tumor cells. (A) Example of images of A549 stably transfected with the GFP-LC3 construct (A549 GFP-LC3) treated or not (NT) with an autophagy inducer, the rapamycin (Rapa., 1 µM) or by synthetic TLR7 agonists, CL264 (1 mM) and loxoribin (Loxo., 1 mM) for 6h. The graph represents the quantification of the GFP-LC3 dots per cell in each condition at 6 h post-treatment. The experiment was performed six times. (B) The same experiment as in A was performed with different kinetics: 6, 24, and 48h post-treatments. The graph represents the evolution of the GFP-LC3 dots per cell in each condition over time. The experiment was performed six times. (C) Example of images of A549 GFP-LC3 treated or not (NT) with either inhibitors of the autophagy maturation, <t>Leupeptin</t> and E64d (L + E, 1 ug/mL each), an autophagy inducer (Rapa., 1 µM) or synthetic TLR7 agonists (CL264 and Loxo., 1 mM) for 24 h. The graph represents the quantification of the GFP-LC3 dots per cell in each condition. The experiment was performed three times. (D) Example of images of A549 GFP-LC3 treated or not (NT) with either an inhibitor of the autophagy maturation, the Baf. (100 nM), an autophagy inducer (Rapa., 1 µM) or synthetic TLR7 agonists (Loxo., 1 mM) for 24 h. Lysosomes were marked in red by the addition of lysotracker 90 minutes before the end of the experiment. The graph represents the study of pixel colocalization (green versus red puncta) using the coloc2 script from the ImageJ software. The experiment was performed three times. (E) A549 cells were transfected with a plasmid encoding a dual-labeled LC3 probe, RFP-GFP-LC3. Cells were again treated with Rapa. or with Loxo. (1 mM) for 24 h. Representative images are shown and the number of total autophagic vacuoles (GFP + RFP + + GFP − RFP + ), autophagosomes (GFP + RFP + ), and autolysosomes (GFP − RFP + ) were enumerate. The inset permits visualization of yellow autophagosome (yellow arrow) and red autolysosomes (red arrow). The experiment was performed three times. (F) At the left: measurement of the proportion of lung tumor cells LC3 positive versus negative for both TLR7 low (proportion of lung tumor cells expressing TLR7 <78%) versus TLR7 high (proportion of lung tumor cells expressing TLR7 >78%) NSCLC patients of the cohort 1. In the right: implementation of an autophagy score (score 1, proportion of lung tumor cells LC3 pos <25%; 2, 25%< x <50%; 3, 50%< x <75% and 4, x >75%). Evaluation of the TLR7 expression level in function of the autophagy score. (G) The same analysis as in E was carried out on the NSCLC patients from cohort 2, those treated by neoadjuvant chemotherapies. Student’s t -test, *, P<0.05. Baf., bafilomycin; GFP, green fluorescent protein; LC3, light chain 3; Loxo., loxoribin; NSCLC, non-small cell lung cancer; Rapa., rapamycin; RFP, red fluorescent protein; TLR7, toll-like receptor 7.
    Leupeptin Hemisulfate, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/leupeptin/pmc13186664-168-8-12?v=Thermo+Fisher
    Average 94 stars, based on 1 article reviews
    leupeptin hemisulfate - by Bioz Stars, 2026-07
    94/100 stars
      Buy from Supplier

    86
    Merck & Co leupeptin
    Study the impact of TLR7 on the autophagy level in lung tumor cells. (A) Example of images of A549 stably transfected with the GFP-LC3 construct (A549 GFP-LC3) treated or not (NT) with an autophagy inducer, the rapamycin (Rapa., 1 µM) or by synthetic TLR7 agonists, CL264 (1 mM) and loxoribin (Loxo., 1 mM) for 6h. The graph represents the quantification of the GFP-LC3 dots per cell in each condition at 6 h post-treatment. The experiment was performed six times. (B) The same experiment as in A was performed with different kinetics: 6, 24, and 48h post-treatments. The graph represents the evolution of the GFP-LC3 dots per cell in each condition over time. The experiment was performed six times. (C) Example of images of A549 GFP-LC3 treated or not (NT) with either inhibitors of the autophagy maturation, <t>Leupeptin</t> and E64d (L + E, 1 ug/mL each), an autophagy inducer (Rapa., 1 µM) or synthetic TLR7 agonists (CL264 and Loxo., 1 mM) for 24 h. The graph represents the quantification of the GFP-LC3 dots per cell in each condition. The experiment was performed three times. (D) Example of images of A549 GFP-LC3 treated or not (NT) with either an inhibitor of the autophagy maturation, the Baf. (100 nM), an autophagy inducer (Rapa., 1 µM) or synthetic TLR7 agonists (Loxo., 1 mM) for 24 h. Lysosomes were marked in red by the addition of lysotracker 90 minutes before the end of the experiment. The graph represents the study of pixel colocalization (green versus red puncta) using the coloc2 script from the ImageJ software. The experiment was performed three times. (E) A549 cells were transfected with a plasmid encoding a dual-labeled LC3 probe, RFP-GFP-LC3. Cells were again treated with Rapa. or with Loxo. (1 mM) for 24 h. Representative images are shown and the number of total autophagic vacuoles (GFP + RFP + + GFP − RFP + ), autophagosomes (GFP + RFP + ), and autolysosomes (GFP − RFP + ) were enumerate. The inset permits visualization of yellow autophagosome (yellow arrow) and red autolysosomes (red arrow). The experiment was performed three times. (F) At the left: measurement of the proportion of lung tumor cells LC3 positive versus negative for both TLR7 low (proportion of lung tumor cells expressing TLR7 <78%) versus TLR7 high (proportion of lung tumor cells expressing TLR7 >78%) NSCLC patients of the cohort 1. In the right: implementation of an autophagy score (score 1, proportion of lung tumor cells LC3 pos <25%; 2, 25%< x <50%; 3, 50%< x <75% and 4, x >75%). Evaluation of the TLR7 expression level in function of the autophagy score. (G) The same analysis as in E was carried out on the NSCLC patients from cohort 2, those treated by neoadjuvant chemotherapies. Student’s t -test, *, P<0.05. Baf., bafilomycin; GFP, green fluorescent protein; LC3, light chain 3; Loxo., loxoribin; NSCLC, non-small cell lung cancer; Rapa., rapamycin; RFP, red fluorescent protein; TLR7, toll-like receptor 7.
    Leupeptin, supplied by Merck & Co, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/leupeptin/bio_rxiv__64898__2026__03__24__714005-173-29-30?v=Merck+%26+Co
    Average 86 stars, based on 1 article reviews
    leupeptin - by Bioz Stars, 2026-07
    86/100 stars
      Buy from Supplier

    92
    Santa Cruz Biotechnology leupeptin
    Study the impact of TLR7 on the autophagy level in lung tumor cells. (A) Example of images of A549 stably transfected with the GFP-LC3 construct (A549 GFP-LC3) treated or not (NT) with an autophagy inducer, the rapamycin (Rapa., 1 µM) or by synthetic TLR7 agonists, CL264 (1 mM) and loxoribin (Loxo., 1 mM) for 6h. The graph represents the quantification of the GFP-LC3 dots per cell in each condition at 6 h post-treatment. The experiment was performed six times. (B) The same experiment as in A was performed with different kinetics: 6, 24, and 48h post-treatments. The graph represents the evolution of the GFP-LC3 dots per cell in each condition over time. The experiment was performed six times. (C) Example of images of A549 GFP-LC3 treated or not (NT) with either inhibitors of the autophagy maturation, <t>Leupeptin</t> and E64d (L + E, 1 ug/mL each), an autophagy inducer (Rapa., 1 µM) or synthetic TLR7 agonists (CL264 and Loxo., 1 mM) for 24 h. The graph represents the quantification of the GFP-LC3 dots per cell in each condition. The experiment was performed three times. (D) Example of images of A549 GFP-LC3 treated or not (NT) with either an inhibitor of the autophagy maturation, the Baf. (100 nM), an autophagy inducer (Rapa., 1 µM) or synthetic TLR7 agonists (Loxo., 1 mM) for 24 h. Lysosomes were marked in red by the addition of lysotracker 90 minutes before the end of the experiment. The graph represents the study of pixel colocalization (green versus red puncta) using the coloc2 script from the ImageJ software. The experiment was performed three times. (E) A549 cells were transfected with a plasmid encoding a dual-labeled LC3 probe, RFP-GFP-LC3. Cells were again treated with Rapa. or with Loxo. (1 mM) for 24 h. Representative images are shown and the number of total autophagic vacuoles (GFP + RFP + + GFP − RFP + ), autophagosomes (GFP + RFP + ), and autolysosomes (GFP − RFP + ) were enumerate. The inset permits visualization of yellow autophagosome (yellow arrow) and red autolysosomes (red arrow). The experiment was performed three times. (F) At the left: measurement of the proportion of lung tumor cells LC3 positive versus negative for both TLR7 low (proportion of lung tumor cells expressing TLR7 <78%) versus TLR7 high (proportion of lung tumor cells expressing TLR7 >78%) NSCLC patients of the cohort 1. In the right: implementation of an autophagy score (score 1, proportion of lung tumor cells LC3 pos <25%; 2, 25%< x <50%; 3, 50%< x <75% and 4, x >75%). Evaluation of the TLR7 expression level in function of the autophagy score. (G) The same analysis as in E was carried out on the NSCLC patients from cohort 2, those treated by neoadjuvant chemotherapies. Student’s t -test, *, P<0.05. Baf., bafilomycin; GFP, green fluorescent protein; LC3, light chain 3; Loxo., loxoribin; NSCLC, non-small cell lung cancer; Rapa., rapamycin; RFP, red fluorescent protein; TLR7, toll-like receptor 7.
    Leupeptin, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/leupeptin/pm41888978-96-88-89?v=Santa+Cruz+Biotechnology
    Average 92 stars, based on 1 article reviews
    leupeptin - by Bioz Stars, 2026-07
    92/100 stars
      Buy from Supplier

    86
    Merck & Co k 120 5 leupeptin merck
    Study the impact of TLR7 on the autophagy level in lung tumor cells. (A) Example of images of A549 stably transfected with the GFP-LC3 construct (A549 GFP-LC3) treated or not (NT) with an autophagy inducer, the rapamycin (Rapa., 1 µM) or by synthetic TLR7 agonists, CL264 (1 mM) and loxoribin (Loxo., 1 mM) for 6h. The graph represents the quantification of the GFP-LC3 dots per cell in each condition at 6 h post-treatment. The experiment was performed six times. (B) The same experiment as in A was performed with different kinetics: 6, 24, and 48h post-treatments. The graph represents the evolution of the GFP-LC3 dots per cell in each condition over time. The experiment was performed six times. (C) Example of images of A549 GFP-LC3 treated or not (NT) with either inhibitors of the autophagy maturation, <t>Leupeptin</t> and E64d (L + E, 1 ug/mL each), an autophagy inducer (Rapa., 1 µM) or synthetic TLR7 agonists (CL264 and Loxo., 1 mM) for 24 h. The graph represents the quantification of the GFP-LC3 dots per cell in each condition. The experiment was performed three times. (D) Example of images of A549 GFP-LC3 treated or not (NT) with either an inhibitor of the autophagy maturation, the Baf. (100 nM), an autophagy inducer (Rapa., 1 µM) or synthetic TLR7 agonists (Loxo., 1 mM) for 24 h. Lysosomes were marked in red by the addition of lysotracker 90 minutes before the end of the experiment. The graph represents the study of pixel colocalization (green versus red puncta) using the coloc2 script from the ImageJ software. The experiment was performed three times. (E) A549 cells were transfected with a plasmid encoding a dual-labeled LC3 probe, RFP-GFP-LC3. Cells were again treated with Rapa. or with Loxo. (1 mM) for 24 h. Representative images are shown and the number of total autophagic vacuoles (GFP + RFP + + GFP − RFP + ), autophagosomes (GFP + RFP + ), and autolysosomes (GFP − RFP + ) were enumerate. The inset permits visualization of yellow autophagosome (yellow arrow) and red autolysosomes (red arrow). The experiment was performed three times. (F) At the left: measurement of the proportion of lung tumor cells LC3 positive versus negative for both TLR7 low (proportion of lung tumor cells expressing TLR7 <78%) versus TLR7 high (proportion of lung tumor cells expressing TLR7 >78%) NSCLC patients of the cohort 1. In the right: implementation of an autophagy score (score 1, proportion of lung tumor cells LC3 pos <25%; 2, 25%< x <50%; 3, 50%< x <75% and 4, x >75%). Evaluation of the TLR7 expression level in function of the autophagy score. (G) The same analysis as in E was carried out on the NSCLC patients from cohort 2, those treated by neoadjuvant chemotherapies. Student’s t -test, *, P<0.05. Baf., bafilomycin; GFP, green fluorescent protein; LC3, light chain 3; Loxo., loxoribin; NSCLC, non-small cell lung cancer; Rapa., rapamycin; RFP, red fluorescent protein; TLR7, toll-like receptor 7.
    K 120 5 Leupeptin Merck, supplied by Merck & Co, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/leupeptin/pm41864206-258-84-86?v=Merck+%26+Co
    Average 86 stars, based on 1 article reviews
    k 120 5 leupeptin merck - by Bioz Stars, 2026-07
    86/100 stars
      Buy from Supplier

    95
    MedChemExpress g398 leupeptin hemisulfate mce
    Study the impact of TLR7 on the autophagy level in lung tumor cells. (A) Example of images of A549 stably transfected with the GFP-LC3 construct (A549 GFP-LC3) treated or not (NT) with an autophagy inducer, the rapamycin (Rapa., 1 µM) or by synthetic TLR7 agonists, CL264 (1 mM) and loxoribin (Loxo., 1 mM) for 6h. The graph represents the quantification of the GFP-LC3 dots per cell in each condition at 6 h post-treatment. The experiment was performed six times. (B) The same experiment as in A was performed with different kinetics: 6, 24, and 48h post-treatments. The graph represents the evolution of the GFP-LC3 dots per cell in each condition over time. The experiment was performed six times. (C) Example of images of A549 GFP-LC3 treated or not (NT) with either inhibitors of the autophagy maturation, <t>Leupeptin</t> and E64d (L + E, 1 ug/mL each), an autophagy inducer (Rapa., 1 µM) or synthetic TLR7 agonists (CL264 and Loxo., 1 mM) for 24 h. The graph represents the quantification of the GFP-LC3 dots per cell in each condition. The experiment was performed three times. (D) Example of images of A549 GFP-LC3 treated or not (NT) with either an inhibitor of the autophagy maturation, the Baf. (100 nM), an autophagy inducer (Rapa., 1 µM) or synthetic TLR7 agonists (Loxo., 1 mM) for 24 h. Lysosomes were marked in red by the addition of lysotracker 90 minutes before the end of the experiment. The graph represents the study of pixel colocalization (green versus red puncta) using the coloc2 script from the ImageJ software. The experiment was performed three times. (E) A549 cells were transfected with a plasmid encoding a dual-labeled LC3 probe, RFP-GFP-LC3. Cells were again treated with Rapa. or with Loxo. (1 mM) for 24 h. Representative images are shown and the number of total autophagic vacuoles (GFP + RFP + + GFP − RFP + ), autophagosomes (GFP + RFP + ), and autolysosomes (GFP − RFP + ) were enumerate. The inset permits visualization of yellow autophagosome (yellow arrow) and red autolysosomes (red arrow). The experiment was performed three times. (F) At the left: measurement of the proportion of lung tumor cells LC3 positive versus negative for both TLR7 low (proportion of lung tumor cells expressing TLR7 <78%) versus TLR7 high (proportion of lung tumor cells expressing TLR7 >78%) NSCLC patients of the cohort 1. In the right: implementation of an autophagy score (score 1, proportion of lung tumor cells LC3 pos <25%; 2, 25%< x <50%; 3, 50%< x <75% and 4, x >75%). Evaluation of the TLR7 expression level in function of the autophagy score. (G) The same analysis as in E was carried out on the NSCLC patients from cohort 2, those treated by neoadjuvant chemotherapies. Student’s t -test, *, P<0.05. Baf., bafilomycin; GFP, green fluorescent protein; LC3, light chain 3; Loxo., loxoribin; NSCLC, non-small cell lung cancer; Rapa., rapamycin; RFP, red fluorescent protein; TLR7, toll-like receptor 7.
    G398 Leupeptin Hemisulfate Mce, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/leupeptin/10__1016_slash_j__cub__2026__02__055-159-102-105?v=MedChemExpress
    Average 95 stars, based on 1 article reviews
    g398 leupeptin hemisulfate mce - by Bioz Stars, 2026-07
    95/100 stars
      Buy from Supplier

    86
    Fisher Scientific protease inhibitors leupeptin
    Study the impact of TLR7 on the autophagy level in lung tumor cells. (A) Example of images of A549 stably transfected with the GFP-LC3 construct (A549 GFP-LC3) treated or not (NT) with an autophagy inducer, the rapamycin (Rapa., 1 µM) or by synthetic TLR7 agonists, CL264 (1 mM) and loxoribin (Loxo., 1 mM) for 6h. The graph represents the quantification of the GFP-LC3 dots per cell in each condition at 6 h post-treatment. The experiment was performed six times. (B) The same experiment as in A was performed with different kinetics: 6, 24, and 48h post-treatments. The graph represents the evolution of the GFP-LC3 dots per cell in each condition over time. The experiment was performed six times. (C) Example of images of A549 GFP-LC3 treated or not (NT) with either inhibitors of the autophagy maturation, <t>Leupeptin</t> and E64d (L + E, 1 ug/mL each), an autophagy inducer (Rapa., 1 µM) or synthetic TLR7 agonists (CL264 and Loxo., 1 mM) for 24 h. The graph represents the quantification of the GFP-LC3 dots per cell in each condition. The experiment was performed three times. (D) Example of images of A549 GFP-LC3 treated or not (NT) with either an inhibitor of the autophagy maturation, the Baf. (100 nM), an autophagy inducer (Rapa., 1 µM) or synthetic TLR7 agonists (Loxo., 1 mM) for 24 h. Lysosomes were marked in red by the addition of lysotracker 90 minutes before the end of the experiment. The graph represents the study of pixel colocalization (green versus red puncta) using the coloc2 script from the ImageJ software. The experiment was performed three times. (E) A549 cells were transfected with a plasmid encoding a dual-labeled LC3 probe, RFP-GFP-LC3. Cells were again treated with Rapa. or with Loxo. (1 mM) for 24 h. Representative images are shown and the number of total autophagic vacuoles (GFP + RFP + + GFP − RFP + ), autophagosomes (GFP + RFP + ), and autolysosomes (GFP − RFP + ) were enumerate. The inset permits visualization of yellow autophagosome (yellow arrow) and red autolysosomes (red arrow). The experiment was performed three times. (F) At the left: measurement of the proportion of lung tumor cells LC3 positive versus negative for both TLR7 low (proportion of lung tumor cells expressing TLR7 <78%) versus TLR7 high (proportion of lung tumor cells expressing TLR7 >78%) NSCLC patients of the cohort 1. In the right: implementation of an autophagy score (score 1, proportion of lung tumor cells LC3 pos <25%; 2, 25%< x <50%; 3, 50%< x <75% and 4, x >75%). Evaluation of the TLR7 expression level in function of the autophagy score. (G) The same analysis as in E was carried out on the NSCLC patients from cohort 2, those treated by neoadjuvant chemotherapies. Student’s t -test, *, P<0.05. Baf., bafilomycin; GFP, green fluorescent protein; LC3, light chain 3; Loxo., loxoribin; NSCLC, non-small cell lung cancer; Rapa., rapamycin; RFP, red fluorescent protein; TLR7, toll-like receptor 7.
    Protease Inhibitors Leupeptin, supplied by Fisher Scientific, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/leupeptin/pm41759781-95-30-34?v=Fisher+Scientific
    Average 86 stars, based on 1 article reviews
    protease inhibitors leupeptin - by Bioz Stars, 2026-07
    86/100 stars
      Buy from Supplier

    94
    Thermo Fisher leupeptin
    Study the impact of TLR7 on the autophagy level in lung tumor cells. (A) Example of images of A549 stably transfected with the GFP-LC3 construct (A549 GFP-LC3) treated or not (NT) with an autophagy inducer, the rapamycin (Rapa., 1 µM) or by synthetic TLR7 agonists, CL264 (1 mM) and loxoribin (Loxo., 1 mM) for 6h. The graph represents the quantification of the GFP-LC3 dots per cell in each condition at 6 h post-treatment. The experiment was performed six times. (B) The same experiment as in A was performed with different kinetics: 6, 24, and 48h post-treatments. The graph represents the evolution of the GFP-LC3 dots per cell in each condition over time. The experiment was performed six times. (C) Example of images of A549 GFP-LC3 treated or not (NT) with either inhibitors of the autophagy maturation, <t>Leupeptin</t> and E64d (L + E, 1 ug/mL each), an autophagy inducer (Rapa., 1 µM) or synthetic TLR7 agonists (CL264 and Loxo., 1 mM) for 24 h. The graph represents the quantification of the GFP-LC3 dots per cell in each condition. The experiment was performed three times. (D) Example of images of A549 GFP-LC3 treated or not (NT) with either an inhibitor of the autophagy maturation, the Baf. (100 nM), an autophagy inducer (Rapa., 1 µM) or synthetic TLR7 agonists (Loxo., 1 mM) for 24 h. Lysosomes were marked in red by the addition of lysotracker 90 minutes before the end of the experiment. The graph represents the study of pixel colocalization (green versus red puncta) using the coloc2 script from the ImageJ software. The experiment was performed three times. (E) A549 cells were transfected with a plasmid encoding a dual-labeled LC3 probe, RFP-GFP-LC3. Cells were again treated with Rapa. or with Loxo. (1 mM) for 24 h. Representative images are shown and the number of total autophagic vacuoles (GFP + RFP + + GFP − RFP + ), autophagosomes (GFP + RFP + ), and autolysosomes (GFP − RFP + ) were enumerate. The inset permits visualization of yellow autophagosome (yellow arrow) and red autolysosomes (red arrow). The experiment was performed three times. (F) At the left: measurement of the proportion of lung tumor cells LC3 positive versus negative for both TLR7 low (proportion of lung tumor cells expressing TLR7 <78%) versus TLR7 high (proportion of lung tumor cells expressing TLR7 >78%) NSCLC patients of the cohort 1. In the right: implementation of an autophagy score (score 1, proportion of lung tumor cells LC3 pos <25%; 2, 25%< x <50%; 3, 50%< x <75% and 4, x >75%). Evaluation of the TLR7 expression level in function of the autophagy score. (G) The same analysis as in E was carried out on the NSCLC patients from cohort 2, those treated by neoadjuvant chemotherapies. Student’s t -test, *, P<0.05. Baf., bafilomycin; GFP, green fluorescent protein; LC3, light chain 3; Loxo., loxoribin; NSCLC, non-small cell lung cancer; Rapa., rapamycin; RFP, red fluorescent protein; TLR7, toll-like receptor 7.
    Leupeptin, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/leupeptin/pm41692063-58-12-16?v=Thermo+Fisher
    Average 94 stars, based on 1 article reviews
    leupeptin - by Bioz Stars, 2026-07
    94/100 stars
      Buy from Supplier

    Image Search Results


    Study the impact of TLR7 on the autophagy level in lung tumor cells. (A) Example of images of A549 stably transfected with the GFP-LC3 construct (A549 GFP-LC3) treated or not (NT) with an autophagy inducer, the rapamycin (Rapa., 1 µM) or by synthetic TLR7 agonists, CL264 (1 mM) and loxoribin (Loxo., 1 mM) for 6h. The graph represents the quantification of the GFP-LC3 dots per cell in each condition at 6 h post-treatment. The experiment was performed six times. (B) The same experiment as in A was performed with different kinetics: 6, 24, and 48h post-treatments. The graph represents the evolution of the GFP-LC3 dots per cell in each condition over time. The experiment was performed six times. (C) Example of images of A549 GFP-LC3 treated or not (NT) with either inhibitors of the autophagy maturation, Leupeptin and E64d (L + E, 1 ug/mL each), an autophagy inducer (Rapa., 1 µM) or synthetic TLR7 agonists (CL264 and Loxo., 1 mM) for 24 h. The graph represents the quantification of the GFP-LC3 dots per cell in each condition. The experiment was performed three times. (D) Example of images of A549 GFP-LC3 treated or not (NT) with either an inhibitor of the autophagy maturation, the Baf. (100 nM), an autophagy inducer (Rapa., 1 µM) or synthetic TLR7 agonists (Loxo., 1 mM) for 24 h. Lysosomes were marked in red by the addition of lysotracker 90 minutes before the end of the experiment. The graph represents the study of pixel colocalization (green versus red puncta) using the coloc2 script from the ImageJ software. The experiment was performed three times. (E) A549 cells were transfected with a plasmid encoding a dual-labeled LC3 probe, RFP-GFP-LC3. Cells were again treated with Rapa. or with Loxo. (1 mM) for 24 h. Representative images are shown and the number of total autophagic vacuoles (GFP + RFP + + GFP − RFP + ), autophagosomes (GFP + RFP + ), and autolysosomes (GFP − RFP + ) were enumerate. The inset permits visualization of yellow autophagosome (yellow arrow) and red autolysosomes (red arrow). The experiment was performed three times. (F) At the left: measurement of the proportion of lung tumor cells LC3 positive versus negative for both TLR7 low (proportion of lung tumor cells expressing TLR7 <78%) versus TLR7 high (proportion of lung tumor cells expressing TLR7 >78%) NSCLC patients of the cohort 1. In the right: implementation of an autophagy score (score 1, proportion of lung tumor cells LC3 pos <25%; 2, 25%< x <50%; 3, 50%< x <75% and 4, x >75%). Evaluation of the TLR7 expression level in function of the autophagy score. (G) The same analysis as in E was carried out on the NSCLC patients from cohort 2, those treated by neoadjuvant chemotherapies. Student’s t -test, *, P<0.05. Baf., bafilomycin; GFP, green fluorescent protein; LC3, light chain 3; Loxo., loxoribin; NSCLC, non-small cell lung cancer; Rapa., rapamycin; RFP, red fluorescent protein; TLR7, toll-like receptor 7.

    Journal: Translational Lung Cancer Research

    Article Title: TLR7 induces autophagy in non-small cell lung cancer tumor cells and influences anti-tumors responses in patients

    doi: 10.21037/tlcr-2025-aw-1173

    Figure Lengend Snippet: Study the impact of TLR7 on the autophagy level in lung tumor cells. (A) Example of images of A549 stably transfected with the GFP-LC3 construct (A549 GFP-LC3) treated or not (NT) with an autophagy inducer, the rapamycin (Rapa., 1 µM) or by synthetic TLR7 agonists, CL264 (1 mM) and loxoribin (Loxo., 1 mM) for 6h. The graph represents the quantification of the GFP-LC3 dots per cell in each condition at 6 h post-treatment. The experiment was performed six times. (B) The same experiment as in A was performed with different kinetics: 6, 24, and 48h post-treatments. The graph represents the evolution of the GFP-LC3 dots per cell in each condition over time. The experiment was performed six times. (C) Example of images of A549 GFP-LC3 treated or not (NT) with either inhibitors of the autophagy maturation, Leupeptin and E64d (L + E, 1 ug/mL each), an autophagy inducer (Rapa., 1 µM) or synthetic TLR7 agonists (CL264 and Loxo., 1 mM) for 24 h. The graph represents the quantification of the GFP-LC3 dots per cell in each condition. The experiment was performed three times. (D) Example of images of A549 GFP-LC3 treated or not (NT) with either an inhibitor of the autophagy maturation, the Baf. (100 nM), an autophagy inducer (Rapa., 1 µM) or synthetic TLR7 agonists (Loxo., 1 mM) for 24 h. Lysosomes were marked in red by the addition of lysotracker 90 minutes before the end of the experiment. The graph represents the study of pixel colocalization (green versus red puncta) using the coloc2 script from the ImageJ software. The experiment was performed three times. (E) A549 cells were transfected with a plasmid encoding a dual-labeled LC3 probe, RFP-GFP-LC3. Cells were again treated with Rapa. or with Loxo. (1 mM) for 24 h. Representative images are shown and the number of total autophagic vacuoles (GFP + RFP + + GFP − RFP + ), autophagosomes (GFP + RFP + ), and autolysosomes (GFP − RFP + ) were enumerate. The inset permits visualization of yellow autophagosome (yellow arrow) and red autolysosomes (red arrow). The experiment was performed three times. (F) At the left: measurement of the proportion of lung tumor cells LC3 positive versus negative for both TLR7 low (proportion of lung tumor cells expressing TLR7 <78%) versus TLR7 high (proportion of lung tumor cells expressing TLR7 >78%) NSCLC patients of the cohort 1. In the right: implementation of an autophagy score (score 1, proportion of lung tumor cells LC3 pos <25%; 2, 25%< x <50%; 3, 50%< x <75% and 4, x >75%). Evaluation of the TLR7 expression level in function of the autophagy score. (G) The same analysis as in E was carried out on the NSCLC patients from cohort 2, those treated by neoadjuvant chemotherapies. Student’s t -test, *, P<0.05. Baf., bafilomycin; GFP, green fluorescent protein; LC3, light chain 3; Loxo., loxoribin; NSCLC, non-small cell lung cancer; Rapa., rapamycin; RFP, red fluorescent protein; TLR7, toll-like receptor 7.

    Article Snippet: A1 (100 nM, Sigma) or a combination of leupeptin hemisulfate (1 μg/mL, Invitrogen) and E64D (1 μg/mL, Invitrogen).

    Techniques: Stable Transfection, Transfection, Construct, Software, Plasmid Preparation, Labeling, Expressing